Comerica Securities’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-3,035
Closed -$281K 449
2019
Q2
$281K Sell
3,035
-279
-8% -$26.5K 0.03% 356
2019
Q1
$313K Sell
3,314
-4,060
-55% -$355K 0.04% 333
2018
Q4
$473K Sell
7,374
-2,304
-24% -$170K 0.06% 253
2018
Q3
$866K Sell
9,678
-1,237
-11% -$109K 0.1% 212
2018
Q2
$867K Sell
10,915
-498
-4% -$41.3K 0.11% 213
2018
Q1
$1.02M Sell
11,413
-7,833
-41% -$752K 0.13% 191
2017
Q4
$2.01M Sell
19,246
-6,893
-26% -$778K 0.25% 106
2017
Q3
$3.81M Buy
26,139
+1,568
+6% +$214K 0.53% 45
2017
Q2
$3.19M Buy
24,571
+2,564
+12% +$314K 0.47% 50
2017
Q1
$2.74M Buy
+22,007
New +$2.63M 0.43% 68
2015
Q3
Sell
-5,577
Closed -$645K 363
2015
Q2
$645K Sell
5,577
-257
-4% -$29.4K 0.16% 157
2015
Q1
$673K Buy
+5,834
New +$697K 0.17% 137
2014
Q4
Sell
-5,269
Closed -$499K 182
2014
Q3
$499K Buy
+5,269
New +$475K 0.35% 80

Other funds holding CELG

Comerica Securities's CELG Position: Q3 2019 in Review

Comerica Securities sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 3,035 shares — an estimated $281K sold.

Comerica Securities first reported a position in CELG in Q3 2014 and held it in 13 quarters. The position peaked at $3.81M in Q3 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Comerica Securities reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Comerica Securities sold 3,035 Celgene Corp shares in Q3 2019, an estimated $281K.
  • Comerica Securities first reported a position in Celgene Corp in Q3 2014 and held it in 13 quarters.
  • Comerica Securities's Celgene Corp position peaked at $3.81M in Q3 2017.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Comerica Securities's 13F filing for Q3 2019, filed 15 Oct 2019.